NCT07856667Not yet recruiting
COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease
Cardineurovascular Disease and Obstructive Airway Disease (COINCIDE): A Prospective Longitudinal Observational Cohort Study of Cardiovascular Comorbidities in Patients With COPD and Severe Asthma
Source: ClinicalTrials.gov · Last updated 9 Oct 2026
Brief summary (registry, in English)
Patients with chronic obstructive pulmonary disease (COPD) and severe asthma frequently present with cardiovascular comorbidities that contribute substantially to morbidity and mortality. Early identification and appropriate management of cardiovascular disease are increasingly recognized as important components of comprehensive care for patients with obstructive airway diseases. The COINCIDE study is a prospective longitudinal observational cohort study conducted at the Department of Pulmonology, Medical University of Innsbruck. The study aims to systematically document cardiovascular comorbidities in patients with COPD and severe asthma and to evaluate their association with disease progression, therapeutic management, exacerbation rates, symptom burden, and pulmonary function over time. Clinical, functional, laboratory, and imaging data obtained as part of routine clinical care will be collected prospectively during two study visits separated by approximately 24 months. Up to 350 adult participants will be enrolled and followed over a period of five years.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 28 Sept 2026
- Start date
- 15 Oct 2026
- Primary completion date
- 15 May 2031
- Lead sponsor
- VASCage GmbH
- NCT number
- NCT07856667
What you commit to
- Study type: Observational
- Planned participants: 350
- From 15 Oct 2026 to the primary completion date, 15 May 2031
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age below 18 years.
Other
- Inability or unwillingness to participate in study procedures.
- Inability or unwillingness to provide written informed consent.
- Planned transfer of care preventing longitudinal follow-up.
- Pregnancy.
Who the study is looking for
- Male or female participants aged 18 years or older.
- Diagnosis of COPD GOLD Group B or E according to current GOLD recommendations, or severe asthma according to current GINA recommendations.
- Receiving care at the specialized pulmonary outpatient clinic of the Department of Internal Medicine II, Medical University of Innsbruck.
- Ability to provide written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.